» Articles » PMID: 30590383

Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model

Overview
Journal Ann Behav Med
Specialty Social Sciences
Date 2018 Dec 28
PMID 30590383
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Leventhal's Self-regulatory Model proposes that somatic characteristics of a health threat (e.g., symptom severity), and prior experience with the threat (e.g., unsuccessful treatment), are determinants of illness perceptions. Chronic lymphocytic leukemia (CLL) is appropriate for test of these postulates, having three phases differing in symptom severity and prior treatment experiences: indolent disease requiring no treatment (active surveillance; AS), symptomatic disease requiring a first treatment (FT), and highly symptomatic disease in those who have relapsed and/or failed to respond to prior treatments (relapsed/refractory; RR).

Purpose: To test symptom severity and prior treatment experiences as determinants of illness perceptions, illness perceptions were characterized and contrasted between CLL groups.

Methods: Three hundred and thirty CLL patients (AS, n = 100; FT, n = 78; RR, n = 152) provided illness perception data on one occasion during a surveillance visit (AS) or prior to beginning treatment (FT, RR).

Results: Analysis of variance with planned comparisons revealed that consequences, identity, and concern were least favorable among RR patients, followed by FT, then AS (ps < .01). AS patients endorsed the lowest levels of coherence (ps < .01), and the most chronic illness timeline (ps < .01). FT patients endorsed the highest levels of personal and treatment control (ps < .01).

Conclusions: Data provide preliminary empirical support for Self-regulatory Model postulates that symptom severity and prior disease experiences influence illness perceptions. Unique knowledge needs for AS patients and elevated psychological/physical symptoms for later-stage CLL patients may warrant clinical attention.

Citing Articles

Illness Perception and the Severity of Depression and Anxiety Symptoms in Patients with Multimorbidity: Observational Cohort Studies.

Jaltuszewska S, Chojnacka-Szawlowska G, Majkowicz M, Zdonczyk S, Homenda W, Hebel K J Clin Med. 2024; 13(1).

PMID: 38202075 PMC: 10780102. DOI: 10.3390/jcm13010069.


Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma.

Newcomb R, Johnson P, Yang D, Holmbeck K, Choe J, Nabily A Oncologist. 2023; 29(5):441-449.

PMID: 37935593 PMC: 11067807. DOI: 10.1093/oncolo/oyad295.

References
1.
Dighiero G . Unsolved issues in CLL biology and management. Leukemia. 2003; 17(12):2385-91. DOI: 10.1038/sj.leu.2403154. View

2.
Halm E, Mora P, Leventhal H . No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest. 2006; 129(3):573-80. DOI: 10.1378/chest.129.3.573. View

3.
Broadbent E, Petrie K, Main J, Weinman J . The brief illness perception questionnaire. J Psychosom Res. 2006; 60(6):631-7. DOI: 10.1016/j.jpsychores.2005.10.020. View

4.
Chanan-Khan A, Miller K, Musial L, Lawrence D, Padmanabhan S, Takeshita K . Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study. J Clin Oncol. 2006; 24(34):5343-9. DOI: 10.1200/JCO.2005.05.0401. View

5.
French D, Cooper A, Weinman J . Illness perceptions predict attendance at cardiac rehabilitation following acute myocardial infarction: a systematic review with meta-analysis. J Psychosom Res. 2006; 61(6):757-67. DOI: 10.1016/j.jpsychores.2006.07.029. View